Aberrant Methylation of p16 Tumor Suppressor Gene and Death-Associated Protein Kinase in Non-Small Cell Lung Carcinoma.
10.4046/trd.2001.51.2.108
- Author:
Yun Seong KIM
;
Min Ki LEE
;
Kyung Sik JUNG
;
Ki Uk KIM
;
Young Dae KIM
;
Hyung Ryul LEE
;
Chang Hoon LEE
;
Ju Won SEOK
;
Yong Ki KIM
;
Eun Sook JUN
;
Young Min CHOI
;
Seo Hee RHA
;
Soon Kew PARK
- Publication Type:Original Article
- Keywords:
DNA methylation;
p16;
DAPK;
Non-small cell lung carcinoma;
Methylation-specific PCR
- MeSH:
Adenocarcinoma;
Biomarkers;
Carcinoma, Large Cell;
Carcinoma, Squamous Cell;
Cell Death;
Death-Associated Protein Kinases;
Disease Progression;
DNA Methylation;
Female;
Genes, Tumor Suppressor*;
Humans;
Interferons;
Lung Neoplasms;
Lung*;
Lymph Nodes;
Male;
Methylation*;
Models, Animal;
Neoplasm Metastasis;
Polymerase Chain Reaction;
Promoter Regions, Genetic;
Protein Kinases*;
Smoke;
Smoking
- From:Tuberculosis and Respiratory Diseases
2001;51(2):108-121
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The p16INK4a (p16) tumor suppressor gene is frequently inactivated in human non-small cell lung cancers (NSCLCs), predominantly through homozygous deletion or in association with aberrant promotor hypermethylation. Death-associated protein kinase (DAPK) gene influences interferon γ-induced apoptotic cell death and has important role in metastasis of lung cancer in animal model. Hypermethylation of promoter region of DAP kinase gene may suppress the expression of this gene. METHODS: This study was performed to investigate the aberrant methylation of p16 or DAP kinase in 35 resected primary NSCLCs by methylation-specific PCR (MSP), and demonstrated frequency, diagnostic value and clinical implication of aberrant methylation of two genes. RESULTS: Thirty-two cases were male patients, and 3 cases were female patients with an average age was 57.8±10.5 years. The histologic types of lung cancer were 22 of squamous cell carcinoma, 12 of adenocarcinoma, 1 of large cell carcinoma. Pathologic stages were 11 cases of stage I(1 IA,10 IB), 13 cases of stage II (1 IIA, 12 IIB), and 11 cases of stage III(9 IIIA, 2 IIIB). Regarding for the cancer tissue, p16 aberrant methylation was noted in 13 case of 33 cases (39.4%), DAP kinase in 21 cases of 35 cases (60%). Age over 55 year was associated with p16 aberrant methylation significantly (p<0.05). Methylation status of two genes was not different by smoking history, histologic type, size of tumor, lymph node metastasis and disease progression of lung cancer. There was no correlation between p16 and DAP kinase hypermethylation. CONCLUSION: This investigation demonstrates that aberrant methylation of p16 tumor suppressor gene or DAP kinase showed relatively high frequency (74.3%) in NSCLCs, and that these genes could be a biologic marker for early detection of lung cancer.
